Doctor profile · Federal record
Dr. Brian Gasser, NP
Nurse Practitioner · Nephi, UT
- NPI 1194744615
- Accepts Medicare
- MIPS 97.4 / 100 · 2023
- 26 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
48 W 1500 N
Nephi, UT 846488900
(435) 623-3200
fax (435) 623-3265 - Mailing address
-
681 S 500 W
Payson, UT 846512715
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Utah #207286-4405
- Medicaid
- UT #870419324004
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194744615. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,340
Distinct HCPCS
10
Medicare allowed
$91,170
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,896 | 150 | $5 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 379 | 44 | $1 | |
17000 |
Destruction of precancer skin growth, 1 growth | 319 | 156 | $50 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 238 | 149 | $74 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 155 | 76 | $138 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 104 | 78 | $46 | |
11102 |
Biopsy of related skin growth, first growth | 82 | 72 | $80 | |
96372 |
Injection of drug or substance under skin or into muscle | 67 | 45 | $11 | |
11103 |
Biopsy of related skin growth, each additional growth | 37 | 23 | $41 | |
17110 |
Destruction of skin growth, 1-14 growths | 19 | 15 | $93 |
In context: peer comparison
Among 1 peers in Nephi Nurse Practitioner, average services per provider: 256. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$2,314
Transactions
114
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 29 | $323.66 | |
| Ucb, INC. | 6 | $299.83 | |
| Pfizer INC. | 14 | $293.85 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $282.76 | |
| Sun Pharmaceutical Industries INC. | 7 | $275.39 | |
| Janssen Biotech, INC. | 10 | $165.50 | |
| Novartis Pharmaceuticals Corporation | 15 | $137.89 | |
| Leo Pharma INC. | 6 | $122.19 | |
| Dermavant Sciences, INC. | 7 | $109.21 | |
| Lilly USA, LLC | 4 | $91.42 | |
| Genzyme Corporation | 3 | $73.83 | |
| Amgen INC. | 2 | $30.89 | |
| Kyowa Kirin, INC. | 1 | $27.83 | |
| Biofrontera INC. | 1 | $26.22 | |
| Regeneron Healthcare Solutions, INC. | 1 | $21.45 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
241
Patients
108
Total drug cost
$6,321
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 76 | 34 | $1,774 |
| Triamcinolone Acetonide | Generic | 42 | 32 | $571 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 20 | 0 | $984 |
| Betamethasone Dipropionate | Generic | 18 | 13 | $962 |
| Mupirocin | Generic | 17 | 14 | $171 |
| Clobetasol Propionate | Generic | 15 | 15 | $415 |
| Doxycycline Monohydrate | Generic | 15 | 0 | $228 |
| Doxycycline Hyclate | Generic | 13 | 0 | $273 |
| Montelukast Sodium | Generic | 13 | 0 | $166 |
| Imiquimod | Generic | 12 | 0 | $776 |
Frequently asked questions
What is Dr. Brian Gasser's medical specialty?
Dr. Brian Gasser practices Nurse Practitioner in Nephi, UT.
Where does Dr. Brian Gasser practice?
Dr. Brian Gasser practices at 48 W 1500 N, Nephi, UT 846488900. Office phone: 4356233200.
What is Dr. Brian Gasser's NPI?
Dr. Brian Gasser's National Provider Identifier (NPI) is 1194744615, issued by NPPES.
Does Dr. Brian Gasser accept Medicare assignment?
Yes. Dr. Brian Gasser accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brian Gasser commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.